Avid Bioservices Inc (CDMO)

[biopharm]

Moving along nicely but we have not heard of all the shenanigans in the background surrounding PS Targeting IP ...things will be coming as Kyla Driscoll involved in PS Targeting

June 14 2018

Todays guest blog comes from Kyla Driscoll, Ph.D., senior research advisor and group leader focused on Lillys immuno-oncology drug discovery and development and Emily Collins, Ph.D., senior director of imaging research and development working across the Lilly portfolio including Lillys pain portfolio. Kyla and Emily recently traveled to Washington, D.C. with their Lilly colleague Jirong Lu, Ph.D., to talk about their work with Members of Congress and Capitol Hill staff. Here is a recap of their trip, in their own words.

https://lillypad.lilly.com/entry.php?e=10976